Company Profile
Profil emiten IDX — keuangan, direksi, komisaris, anak usaha
PT Ikapharmindo Putramas Tbk.
IKPM
Sector: Healthcare
Industry: Pharmaceuticals
Sub Sector: Pharmaceuticals & Health Care Research
Sub Industry: Pharmaceuticals
Live quote
tidak tersedia
Highlight Keuangan (2026 Q2) (In Rp)
EPS
3
ROE
2,61%
ROA
1,23%
Book Value
132
Net Income
2,89 M
Total Sales
212,13 M
Total Assets
471,44 M
DER
1.13x
Struktur Pemegang Saham (>1%)
Free Float Information
Saham tersebar di publik
6,84%
PT IKAPHARMA INTI MAS 🔗
78,11%
Corporate · Lokal
REKSA DANA SUCORINVEST DANA SEHAT BERIMBANG 🔗
4,65%
Mutual Funds · Lokal
REKSA DANA SUCORINVEST EQUITY PRIMA FUND 🔗
4,25%
Mutual Funds · Lokal
REKSA DANA SUCORINVEST SHARIA EQUITY FUND 🔗
2,00%
Mutual Funds · Lokal
PT. KASIH ANUGRAH INVESTA 🔗
1,78%
Venture Capital · Lokal
REKSA DANA SUCORINVEST MAXI FUND 🔗
1,19%
Mutual Funds · Lokal
GOLDEN SWAN CAPITAL, PT 🔗
1,18%
Corporate · Lokal
Tentang Perusahaan
PT Ikapharmindo Putramas Tbk (the “Company") was established under the name of PT Ikapharm Indonesia based on Notarial Deed of Lien Tanudirdja, S.H., No. 63 dated May 18, 1978. The Company started its commercial operations in 1978. PT Ikapharma Inti Mas is the Parent Company of the Company.
Produk & Lini Bisnis
Business of The Company is pharmaceutical and personal care industry.
Dewan Direksi
K
Kartono
President Director / Indp
AS
Ayi Saepudin
Independent Director
EA
Eliza Arlena Winata
Director
Dewan Komisaris
MR
Maudy Ratna Winata
President Commissioner
TW
Titianus Winata
Commissioner
SL
Susanto Lam
Independent Commissioner
Anak Usaha & Afiliasi
NamaDomisili%
PT Distriversa Buanamas
Pharmaceutical wholesaler
 Jakarta 97.50%
Trend Keuangan (5 periode terakhir) — hover bar untuk detail
Total Sales Net Income (+) Net Income (-)
364jt 273jt 182jt 91jt 0 Sales 2025Q2: Rp 175.446.652 Net Income 2025Q2: Rp -9.139.874 2025Q2 Sales 2025Q3: Rp 257.098.995 Net Income 2025Q3: Rp -31.954.141 2025Q3 Sales 2025Q4: Rp 363.565.142 Net Income 2025Q4: Rp -28.784.661 2025Q4 Sales 2026Q1: Rp 103.843.219 Net Income 2026Q1: Rp 877.412 2026Q1 Sales 2026Q2: Rp 212.130.603 Net Income 2026Q2: Rp 2.889.896 2026Q2
2025 Q2
EPS -11
ROE -7,71%
2025 Q3
EPS -25
ROE -19,90%
2025 Q4
EPS -17
ROE -13,16%
2026 Q1
EPS 2
ROE 1,60%
2026 Q2
EPS 3
ROE 2,61%
Laporan Keuangan Historis (5 Periode Terakhir) (In Rp)
PeriodeTotal SalesNet IncomeTotal AssetsTotal EquityEPSROEDER
2026 Q2 212,13 M 2,89 M 471,44 M 221,63 M 3 2,61% 1.13x
2026 Q1 103,84 M 877,41 Jt 472,90 M 219,61 M 2 1,60% 1.15x
2025 Q4 363,57 M -28,78 M 464,00 M 218,74 M -17 -13,16% 1.12x
2025 Q3 257,10 M -31,95 M 449,90 M 214,15 M -25 -19,90% 1.10x
2025 Q2 175,45 M -9,14 M 476,89 M 236,96 M -11 -7,71% 1.01x
Trend Harga Penutupan & Book Value — hover titik untuk detail
Close Price Book Value
236 207 179 151 122 Book Value 2025Q2: Rp 141 Close 2025Q2: Rp 210 2025Q2 Book Value 2025Q3: Rp 127 Close 2025Q3: Rp 226 2025Q3 Book Value 2025Q4: Rp 130 Close 2025Q4: Rp 224 2025Q4 Book Value 2026Q1: Rp 130 Close 2026Q1: Rp 210 2026Q1 Book Value 2026Q2: Rp 132 Close 2026Q2: Rp 178 2026Q2
2025 Q2
Close 210
BV 141
ROA -3,83%
2025 Q3
Close 226
BV 127
ROA -9,47%
2025 Q4
Close 224
BV 130
ROA -6,20%
2026 Q1
Close 210
BV 130
ROA 0,74%
2026 Q2
Close 178
BV 132
ROA 1,23%
History Harga Penutupan & Book Value
TahunQrtClose Price (Rp)Book Value (Rp)ROA
2026 2 178 132 1,23%
2026 1 210 130 0,74%
2025 4 224 130 -6,20%
2025 3 226 127 -9,47%
2025 2 210 141 -3,83%
Data diperbarui pada: 2026-09-03 15:10:20